As part of our CDMO Services, by precisely controlling the expression of key genes during the differentiation process, we can generate customized cell models that faithfully recapitulate the phenotype and functionality of the target cell type.

These differentiated cell lines can be utilized for

1. Disease Modeling
   

   Validate the impact of disease-associated genetic factors on the differentiated cell type, such as cardiomyocytes.
   Assess disease pathology and test potential therapeutic interventions using patient-derived iPSC models.

2. Drug Screening
   

   Generate motor neurons to evaluate the responsiveness of this clinically-relevant cell type to candidate drug compounds.
   Leverage the consistency and scalability of iPSC-derived cells for high-throughput drug testing.

Our expert team is dedicated to supporting your research needs by providing high-quality, well-characterized iPSC-derived cell lines.
Contact us today to discuss how we can assist in developing the ideal cell models for your project through our specialized CDMO Services.